Astria Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 111,558 | 83,030 | 53,503 | 194,976 | 37,435 |
| Operating Income | -111,558 | -83,030 | -53,503 | -194,976 | -37,435 |
| Other Income | 17,298 | 10,139 | 1,669 | 64 | 135 |
| Pre-tax Income | -94,260 | -72,891 | -51,834 | -194,912 | -37,300 |
| Net Income Continuous | -94,260 | -72,891 | -51,834 | -194,912 | -37,300 |
| Net Income | $-94,260 | $-72,891 | $-51,834 | $-194,912 | $-37,300 |
| EPS Basic Total Ops | -1.68 | -2.42 | -3.55 | -24.58 | -12.20 |
| EPS Basic Continuous Ops | -1.68 | -2.42 | -3.55 | -21.84 | -12.20 |
| EPS Diluted Total Ops | -1.68 | -2.42 | -3.55 | -24.58 | -12.20 |
| EPS Diluted Continuous Ops | -1.68 | -2.42 | -3.55 | -21.84 | -12.20 |
| EPS Diluted Before Non-Recurring Items | -1.68 | -2.42 | -3.55 | -24.58 | -12.18 |
| EBITDA(a) | $-111,558 | $-83,030 | $-53,503 | $-194,976 | $-37,435 |